鼻咽癌不同剂量层级临床靶区勾画国际共识指南(2024版)
该指南由国际专家基于文献复习和德尔菲调查制定,针对鼻咽癌不同剂量层级的临床靶区勾画达成共识。最终调查58个问题中20个(34%)达成共识(≥75%一致),32个(55%)达成同意(60%-74%一致)。与2018版相比,36个参数有变化或澄清,主要涉及诱导化疗后大体肿瘤体积用于70 Gy等效CTV、选择性淋巴结覆盖及较低的选择性剂量50 Gy等效。
要点
- 58个德尔菲问题中20个(34%)达成共识(≥75%一致),32个(55%)达成同意(60%-74%一致)。
- 与IG-2018相比,36个参数有变化或澄清,涉及CTV勾画和剂量。
- 主要差异包括诱导化疗后GTV用于70 Gy等效CTV(p/n)(晚期结外 extension 患者除外)。
核心结论
- 基于更新证据和国际专家集体共识制定了综合共识指南,为不同剂量层级的最佳靶区覆盖提供实用参考,以最大化局部区域控制并最小化毒性,并为自动勾画程序提供指导原则。
研究设计与样本
- 进行综合文献复习评估现有指南和新数据,向来自14个国家/地区26个中心的30名国际专家发放初步问卷,经过投票和迭代后进行德尔菲调查以建立共识。
主要发现
- 初步问卷显示专家在CTV勾画和处方剂量方面临床实践存在显著差异。
- 最终德尔菲调查58个问题中20个(34%)达成共识(≥75%一致),32个(55%)达成同意(60%-74%一致)。
- 与IG-2018相比,36个参数有变化或澄清。
关键数值与推荐
- 使用诱导化疗后大体肿瘤体积(晚期结外 extension 患者除外)用于CTV(p/n)至70 Gy等效。
- 对偏心原发肿瘤逐步细化选择性覆盖至同侧解剖结构。
- 选择性覆盖淋巴结区域。
- 选择性剂量较低,为50 Gy等效。
临床怎么用
- 作为不同剂量层级最佳靶区覆盖的实用参考,以最大化局部区域控制并最小化毒性。
- 为生成自动勾画程序提供指导原则以增强标准化。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Radiation therapy planning for nasopharyngeal carcinoma is one of the most challenging tasks for radiation oncologists due to the notoriously narrow therapeutic margin. The first International Guideline (IG-2018 Version) has served as a practical guide for contouring clinical target volumes (CTVs). With increasing data on locoregional extension patterns and outcomes from studies on optimizing CTV and doses, an updated International Guideline is pressingly needed to provide a reference for enhancing precision. METHODS AND MATERIALS: A comprehensive literature review was conducted to assess existing guidelines and emerging data related to contouring. A preliminary questionnaire was distributed to 30 international experts (from 26 centers in 14 countries/regions) with extensive experience in nasopharyngeal carcinoma treatment, aiming to capture diverse practices and opinions. Following initial voting and iterations, a comprehensive survey was prepared for consensus building. RESULTS: The initial questionnaire revealed marked variations in clinical practices related to CTV contouring and prescribed doses among experts. The final Delphi survey consisted of 58 questions: 20 (34%) parameters attained consensus (≥75% agreement) and 32 (55%) attained agreement (60%-74% agreement). In the current guideline (IG-2024), 36 parameters involved changes/clarifications compared with IG-2018. The major differences focus on the use of postinduction chemotherapy gross tumor volume (except in patients with advanced extranodal extension) for CTV(p/n) to 70 Gy equivalent, stepwise refinement of elective coverage to ipsilateral anatomical structures for eccentric primary tumor, selective coverage of nodal levels, and a lower elective dose of 50 Gy equivalent. CONCLUSIONS: Amidst the challenges of diverging practices, a comprehensive consensus guideline has been devised based on updated evidence and collective agreement among international experts. This serves as a practical reference for optimal target coverage at different dose levels to maximize locoregional control while minimizing toxicities and guiding principles for generating automated contouring programs to enhance standardization.
引用
- Lin SJ, Guo QJ, Liu Q, et al. International Consensus Guideline on Delineation of the Clinical Target Volumes at Different Dose Levels for Nasopharyngeal Carcinoma (2024 Version). Int J Radiat Oncol Biol Phys. 2025. PMID: 40419028. doi:10.1016/j.ijrobp.2025.05.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。